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Available online 21 June 2014Abstract Multiple sclerosis (MS) is a multifocal disease, and precursor cells need to migrate into the multiple lesions in order
to exert their therapeutic effects. Therefore, cell migration is a crucial element in regenerative processes in MS, dictating the
route of delivery, when cell transplantation is considered. We have previously shown that inflammation triggers migration of
multi-potential neural precursor cells (NPCs) into the white matter of experimental autoimmune encephalomyelitis (EAE)
rodents, a widely used model of MS. Here we investigated the molecular basis of this attraction.
NPCs were grown from E13 embryonic mouse brains and transplanted into the lateral cerebral ventricles of EAEmice. Transplanted
NPC migration was directed by three tissue-derived chemokines. Stromal cell-derived factor-1α, monocyte chemo-attractant
protein-1 and hepatocyte growth factor were expressed in the EAE brain and specifically in microglia and astrocytes. Their cognate
receptors, CXCR4, CCR2 or c-Met were constitutively expressed on NPCs. Selective blockage of CXCR4, CCR2 or c-Met partially
inhibited NPCmigration in EAE brains. Blocking all three receptors had an additive effect and resulted in profound inhibition of NPC
migration, as compared to extensive migration of control NPCs. The inflammation-triggered NPC migration into white matter
tracts was dependent on a motile NPC phenotype. Specifically, depriving NPCs from epidermal growth factor (EGF) prevented the
induction of glial commitment and a motile phenotype (as indicated by an in vitro motility assay), hampering their response to
neuroinflammation.
In conclusion, signaling via three chemokine systems accounts for most of the inflammation-induced, tissue-derived attraction
of transplanted NPCs into white matter tracts during EAE.
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Multiple sclerosis (MS) is a chronic immune mediated disease
of the central nervous system (CNS) characterized by peri-
vascular immune cell infiltrates, myelin destruction and
axonal loss, resulting in permanent neurological disability.access article under the CC BY-NC-ND license
228 M.E. Cohen et al.Current therapies help prevent recurrent immune attacks on
the CNS by an immunomodulatory or immunosuppressive
effect, but are inefficient in reversing impaired neurological
functions. Therefore stem cell therapy has been suggested as
a replacement therapy aimed to promote axon remyelination.
Since in MS the immune attack is widespread in the CNS white
matter, transplanted cells need to reach the multiple lesion
sites in order to achieve beneficial local effects.
The experimental autoimmune encephalomyelitis (EAE)
model in mice and rats is widely used to study potential
therapies for MS as it reconstitutes an inflammatory
environment in the white matter. Previous experiments in
our laboratory have shown that migration of transplanted
multi-potential neural precursor cells (NPCs) from the lateral
cerebral ventricles into white matter tracts is triggered by
neuroinflammation: Following intraventricular transplanta-
tion in healthy rodents, the NPCs remained confined to
the ventricles, whereas NPCs that were transplanted into the
ventricles of EAE rodents migrated extensively into the
inflamed white matter (Ben-Hur et al., 2003, 2007; Bulte et
al., 2003; Einstein et al., 2006; Muja et al., 2011) In addition,
transplanted cells are attracted to migrate towards blood
vessels surrounded by immune cell infiltrates (Muja et al.,
2011). While NPC migration into the white matter is driven by
inflammation, the molecular mechanism and specific tissue-
derived inflammatory molecules that play a role in this
attraction during EAE and MS have not been characterized.
Several cytokines and chemokines possess important
chemo-attractant functions during fetal CNS development
(Stumm and Hollt, 2007; Li and Ransohoff, 2008). This
suggests that neural stem and precursor cells may respond
to cues by these mediators of inflammation in immune-
mediated pathological conditions. In vitro migration assays
showed that stromal cell-derived factor 1α (SDF-1α, CXCL12)
enhanced NPC migration in a dose-dependent manner (Robin
et al., 2006). Monocyte chemo-attractant protein-1 (MCP-1,
CCL2) induces migration of adult neural stem cells in-vitro
(Widera et al., 2004) and in an inflammation induced model in
hippocampal slices (Belmadani et al., 2006). In vitro studies
showed that hepatocyte growth factor (HGF) is secreted by
microglia upon TGF-β treatment, attracts oligodendrocyte
precursor cells (Lalive et al., 2005) and is also a powerful
chemo-attractant molecule for neural stem cells (Heese et
al., 2005).
Several pathological conditions lead to the release of
chemokines which trigger the migration of neural stem cells
in vivo. In a stroke model, SDF-1α plays a critical role in
recruiting endogenous stem cells to the lesion site (Imitola
et al., 2004). Brain hypoxia leads to the up-regulation of
vascular-endothelial growth factor (VEGF), stem cell factor
(SCF), SDF-1α, MCP-1, HGF and urokinase-type plasminogen
activator and triggers migration of NPCs (Xu et al., 2007;
Zhao et al., 2008). Brain tumors attract NPCs through
SDF-1α/CXCR4 signaling (van der Meulen et al., 2009),
MCP-1/CCR2 signaling (Magge et al., 2009), or HGF/c-Met
signaling pathways (Heese et al., 2005). In view of these
studies, we examined the role of these factors in mediating
EAE-induced NPC migration.
Herein, we show that inflammation-triggered NPC migra-
tion in white matter tracts during EAE depends on specific
tissue-derived chemokine signaling. Most of NPC migration
into white matter tracts during EAE was accounted for bysignaling through CXCR4, CCR2 and c-Met receptors on NPCs,
by tissue astrocyte- and microglial-derived chemokines. A
pre-requisite to the ability of NPCs to migrate in response
to neuroinflammatory signals is being motile. We show that
exposure to epidermal growth factor induces a motile pheno-
type in NPCs.
Methods
Induction and clinical scoring of EAE
All animal experiments were approved by our institutional
committee. Female 6–7 weeks old SJL mice were immunized
by subcutaneous injection of 150 μg of proteolipid protein
(PLP) peptide 139–151, diluted in normal saline (0.9% NaCl)
and emulsified with complete Freund's adjuvant. Female 6–
7 weeks old C57Bl/6 mice were immunized by subcutaneous
injection of 300 μg of myelin oligodendrocyte glycoprotein
(MOG) peptide corresponding to amino acids 35–55, diluted in
normal saline (0.9% NaCl) and emulsified with complete
Freund's adjuvant. Bordetella pertussis toxin (300 ng; List
Biological Laboratories, Inc.) was diluted in 0.2 ml normal
saline and injected intraperitoneally immediately after PLP
or MOG immunization and two days after MOG immunization
in C57Bl/6 mice. Clinical signs of EAE typically appeared
10–12 days post-immunization, reaching the peak neuro-
logical disability within additional 2–3 days for SJL mice
and 6–10 days for C57Bl/6 mice. Disease progression and
severity was scored daily as follows: 0 = normal; 1 = partial
tail weakness; 2 = flaccid tail 3 = difficulty attaining upright
posture; 4 = hind limb paralysis; 5 = weakness or paralysis in
all limbs/moribund, and 6 = dead. The cumulative score was
calculated as the sum of disease scores of the individual
animals in each experimental group.
Isolation, growth and characterization of
mouse NPCs
NPCs were isolated from the cerebral hemispheres of C57BL/6
E13 embryos of wild type, GFP transgenic or CCR2 knock-
out mice and grown as free-floating neurospheres. Briefly,
cerebral hemispheres were dissociated using EBSS containing
0.25 mg/ml trypsin (5 min at 37 °C) and 10 μg/ml DNase.
Tissue was further dispersed by trituration with a 5 ml
pipette. Dissociated cells were transferred to T-75 flasks and
expanded for 4 days as neurospheres in serum-free DMEM/
F-12 medium supplemented with B27 without vitamin A
(Gibco). Cells were supplemented daily with basic fibroblast
growth factor (FGF2, 10 ng/ml, R&D Biosystem) and epider-
mal growth factor (EGF, 20 ng/ml, Peprotech). In some
experiments NPC spheres were grown in the presence of only
FGF2. For characterization of NPCs, 200–300 neurospheres
were plated on poly-D-lysine (10 μg/ml, Sigma) and fibronec-
tin (0.1% from bovine plasma, Sigma) coated sterile plates.
Immunostaining was performed after 1 h of adhesion or 5 days
of differentiation. Blocking was performed with 3% normal
goat serum (NGS) in phosphate buffered saline (PBS). Primary
antibodies included goat IgG anti-PDGFR-α (1:150, Santa
Cruz Biotech.), rabbit IgG anti-GFAP (1:200, Dako), mouse
IgG anti-βIII-tubulin (1:2000, Sigma), goat anti-c-Met (1:100,
R&D Biosystem), goat anti-CCR2 (1:1000, Abcam) and rabbit
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included goat anti-mouse IgG Alexa Fluor 488 (1:200,Molecular
Probes), goat anti-rabbit IgG Alexa Fluor 488 (1:200, Molecular
Probes), and donkey anti-goat IgG Alexa Fluor 488 (1:200,
Molecular Probes), as appropriate. Cells were fixed with a
solution of 5% acetic acid and 95% ethanol after immunostain-
ing for membranal markers and prior to staining for cytoplas-
mic markers and covered with mounting medium containing
DAPI (Santa Cruz Biotech.)In vitro migration assay
NPCs isolated from wild type C57Bl/6 E13 hemispheres (as
described above) were expanded as spheres in B27 medium
supplemented daily with either EGF (20 μg/ml) and FGF2
(10 μg/ml) or with FGF2 (10 μg/ml) alone. Four days old NPC
spheres were centrifuged and re-suspended in fresh B27
medium. 150 NPC spheres of each group were plated on
separate poly-D-lysine (10 μg/ml, Sigma) and fibronectin
(0.1% from bovine plasma, Sigma) coated sterile plates
in B27 medium without growth factors. After one hour
incubation at 37 °C, the outward migration of neurosphere
cells was evaluated using an inverted microscope. Computer
microscopic images (×100) of individual spheres were ana-
lyzed and classified as spheres with no outward migration,
spheres with migration of up to 2 cell diameters (approxi-
mately 20 μm) from the sphere's border, and spheres with
extensive outward cell migration (over 2 cell diameters).
Statistical analysis was performed by chi-square on a total of
100 spheres per experimental condition, in two independent
experiments. Error bars represent standard deviations.BrdU labeling and blocking chemokine receptors
Neural precursor cell spheres that were grown from wild
type or CCR2 knock-out fetal brain were labeled with BrdU
(2 mM, Sigma) 48 h before transplantation. On the day of
transplantation, neurospheres were incubated for 30 min
at 37°C with anti-mouse c-Met (HGF-receptor) antibody
(2.5 μg/ml, R&D Systems) or at room temperature with
AMD3100, a specific CXCR4 (SDF-1α receptor) antagonist
(Hatse et al., 2002) (5 μg/ml, Sigma), or both agents at
37 °C.TUNEL
200–300 neurospheres were plated on poly-D-lysine and
fibronectin coated sterile plates for adhesion for 1 h. The In
Situ Cell Detection Kit TMR red (Roche) was used to compare
cell death rate with the different treatments.ICV transplantation
2500 neurospheres in 5 μl DMEM/F12 medium were injected
using a Hamilton syringe (catalog #702) on day 8 or 14 post-EAE
induction into each lateral ventricle, using a stereotactic
device (coordinates Bregma A = 0, L = 1 mm, H = 2.2 mm).
The procedure was performed under ketamine (80 mg/kg) and
xylazine (20 mg/kg) anesthesia.Histopathology
Three days after ICV transplantation (day 17 after PLP-EAE
induction, or 21 days after MOG-EAE induction), mice were
deeply anesthetized (sodium pentobarbital, 200 mg/kg i.p.)
and transcardially perfused with ice-cold PBS followed by 4%
formalin. The brains were removed and further fixated by
immersion in 4% formalin for 24 h. Coronal 10 μm thick
frozen sections were cut, and every 6th section was stained
with DAPI to enable anatomic orientation using a mouse
brain atlas. Brain sections were blocked for 1 h using PBS
with 5% normal goat serum and 5% BSA and then incubated
overnight with the primary antibody at 4 °C, followed by 1 h
incubation with the secondary antibody at room tempera-
ture. Primary antibodies included rabbit anti-CD11b (1:200,
IBA1, Wako), rabbit IgG anti-GFAP (1:200, Dako), rabbit anti-
SDF-1α (1:200, Abcam), rabbit anti-MCP-1 (1:200, Abcam),
rabbit anti-HGF (1:200, Abcam), and rat anti-BrdU (1:200,
AbD Serotec). Secondary antibodies used included goat anti-
mouse IgG Alexa Fluor 488 (1:200, Molecular Probes), goat
anti-rabbit IgG Alexa Fluor 488 (1:200, Molecular Probes),
goat anti-rat IgG and IgM Alexa Fluor 555 (1:200, Molecular
Probes). Brain slices were covered with mounting medium
containing DAPI (Santa Cruz Biotech.). Images of specific
immunofluorescent reactivity were obtained using a Nikon
DXm1200F camera attached to an Olympus BX51 microscope
or using a confocal microscope (Zeiss, Feldbach, Switzerland).
Migration measurements
The migration of transplanted cells was evaluated micro-
scopically by GFP fluorescence and BrdU immunostaining.
Serial 10 μm coronal brain sections (105 sections per brain)
were obtained spanning the ventricular system between
Bregma −2.7 and +0.1 mm. All sections were observed
under the fluorescent microscope to identify those with
transplants and parenchymal migration. Measurements were
performed in the corpus callosum of 3 representative
sections for each brain. An ocular grid of determined scale
was used to count the number of squares spanning the entire
distance of migration. The maximal distance of migration
was determined in each section as the distance from the
edge of the ventricle to the most distant migrating cell.
Then, the segment representing the distal third of the entire
migrating cell tract was defined in each section using an
ocular grid. The numbers of GFP+ and BrdU labeled cells were
counted in this defined segment. The number of chemokine
receptor blocked (BrdU+) cells was divided by the number of
control (GFP+) cells, such that an equal number of BrdU+ and
GFP+ cells (representing equal migration) would result in a
proportion of 1.
RNA extraction, cDNA preparation RT-PCR and PCR
Total RNA was extracted from neurospheres using the SV total
RNA kit (Promega). cDNA was prepared from 1 μg of total RNA
using MuLV reverse transcriptase (Applied Biosystems) and
random hexamers according to the manufacturer's instruc-
tions for first-strand cDNA synthesis. The PCR reactionmixture
included 1.5 μl of cDNA, 300 nmol/l concentrations of the
appropriate forward and reverse primers (Syntezza, Israel)
230 M.E. Cohen et al.and 9.5 μl of themastermix buffer containing nucleotides and
Red Load Taq polymerase (Larova) in a total volume of 15 μl.
Gene amplification was carried out using the GeneAmp 9700
Sequence Detection System (Applied Biosystems). Amplifica-
tion included one stage of 10 min at 95 °C, followed by
40 cycles of a two-step loop: 20 s at 95 °C and 1 min at 60 °C.
For real time PCR the reaction mixture included 1 μl of
cDNA, 300 nmol/l concentrations of the appropriate forward
and reverse primers (Syntezza, Israel), and 7.5 μl of SYBR
green mix (SYBR Green Master Mix, Applied Biosystems) in a
total volume of 15 μl. Gene amplification was carried out
using the GeneAmp 7000 PCR system (Applied Biosystems).
The gene expression results were normalized to the HPRT
gene. Two independent experiments were repeated in tripli-
cate and are presented as the standard error (SE) of mean. For
the mRNA quantification, the fold change was normalized to
the HPRT transcript (ΔCT). Following normalization, the fold
change of each mRNA was calculated between the EAE, CNS
tissue and naïve brain reference (ΔΔCT). Statistical significance
of induction of gene expression as compared to its respective
naïve control was calculated using 2-tailed t test.
The following primers were used:Gene Forward ReverseCXCR4 5′-CGGCTGTAGA
GCGAGTGTTG-3′5′-GACCCCACTTCTT
CAGAGTAGTTATCA-3′CCR2 5′-CCATGCAAGT
TCAGCTGCCT-3′5′-TGCCGTGGATGA
ACTGAGG-3′c-Met 5′-TGCAGCGCGT
CGACTTATT-3′5′-TGAGGTGTGCT
GTTCGAGAGAG-3′18S 5′-GGCCCTGTAA
TTGGAA-3′5′-CCCTCCAATGG
ATCCTCGTT-3′Western blot analysis
The cortex, corpus callosum and spinal cord from 4 naïve and
5 EAE (13 days post-induction) SJL mice were homogenized
to 10% (w/v) in cold homogenization buffer (320 mM sucrose;
10 mM EDTA in PBS), followed by centrifugation at 3000 rpm
for 15 min at 4 °C. Homogenates from each group were
pooled and normalized for total protein level using BCA assay
(Pierce); 500 μg from each sample was extracted in 2%
Sarkosyl and boiled for 5 min at 100 °C in sample buffer
containing β-mercaptoethanol. Samples were applied to 8%
(for HGF and PRP detection) or 18% (for SDF-1α and MCP-1
detection) SDS-PAGE and electrotransferred to nitrocellulose
membrane in a Tris/glycine buffer. Membranes were blocked
with 5% milk in TBST (10 mM Tris–HCl, pH 7.4, 150 mM NaCl,
0.05% Tween 20), incubated overnight at 4 °C with rabbit
anti-SDF-1α (Abcam, 1:1000), with goat anti-MCP-1 (R&D
systems, 1:1000), with goat anti-HGF (R&D systems, 1:1000) or
with a rabbit polyclonal anti-prion protein RTC (Canello et al.,
2010, 1:250) primary antibodies, washed and incubated for 1 h
with anti-rabbit or anti-goat AP secondary antibodies
(Promega 1:15,000).
Statistical analysis
Chi square test was used to compare the in vivo and in vitro
motility of NPCs cultured with daily supplementation ofFGF2 versus FGF2 and EGF. Comparisons between treated
and untreated NPC's maximal distance of migration and
number of treated cells in the last portion of migration (+/−
S.E.M.) were performed using the paired 2-tailed Student's
t-test. The effects of NPC spheres on the cumulative daily
score of EAE severity was compared to sham-operated
controls using 2-tailed Student's t-test. Error bars in the
real-time PCR graphs represent the standard error of mean.
Results
Intracerebroventricular transplanted NPCs migrate
in response to neuroinflammation
Our previous studies examined the migratory response of
NPCs to neuroinflammation in MOG-induced EAE in C57Bl/6
mice. Therefore we first examined whether this is a universal
response and whether this occurs in a different model. Neural
precursor cells were isolated from E13 embryonic brains of
GFP transgenic C57Bl/6 mice and expanded in spheres
for 4 days in B27 medium supplemented daily with FGF2 and
EGF. The cells grew into floating neurospheres and were
transplanted into the lateral cerebral ventricles of either
naïve or EAE induced SJL mice (5 animals per group) on day 8
post induction. EAE was induced by immunization with PLP
peptide. Mice brains were examined histologically at day 22.
In naïve mice, transplanted NPCs remained in the ventricles
(Fig. 1A), while in EAE mice NPC spheres migrated extensively
into the corpus callosum (Fig. 1B).
NPCs express chemokine receptors
In view of the role of CXCR4 (receptor of SDF-1α), CCR2
(receptor of MCP-1, MCP-5 and other chemokines) and c-Met
(receptor of HGF) in cell migration during development and
other pathological conditions, we examined their expression
on NPCs. PCR showed the expression of all three receptors
on NPCs (Fig. 2A). In addition, strong immunofluorescent
staining for CXCR4, CCR2 and c-Met was detected on the vast
majority of sphere cells (Figs. 2B–D).
Migration of NPCs in the EAE brain is inhibited by
blocking chemokine receptors on NPCs
Our previous studies indicated that migration of ICV
transplanted NPCs in EAE is a highly variable phenomenon.
Specifically, there was significant variability across individual
animals in the side, tract, direction and extent of NPC
migration, making it difficult to perform a comparison between
groups (Ben-Hur et al., 2007; Muja et al., 2011). Therefore, in
order to evaluate the role of chemokines in determining NPC
migration during EAE we designed an experiment in which the
migration of NPCs whose chemokine receptors were blocked
was directly compared to that of control untreated NPCs that
were co-transplanted into the same animal. First, untreated
BrdU-labeled NPC spheres were mixed with an equal number of
GFP+ NPC spheres and co-transplanted into the lateral ventricle
of PLP-EAE SJL mice. The two cell populations exhibited similar
migratory properties. This enabled us to compare themigration
of BrdU-labeled NPCs in which chemokine receptors were
Figure 1 NPCs migrate into white matter tracts in response to neuro-inflammation. NPC spheres ICV transplanted to naïve mice
were found at 22 days after the injection in the ventricles without migrating into the tissue (A). NPCs that were transplanted on day 8
after EAE induction were observed at day 22 to have migrated extensively into the corpus callosum (B), Scale bar 1 mm.
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were incubated prior to transplantation with either an anti-c-
Met blocking antibody in order to prevent response to HGF, or
with the CXCR4 antagonist AMD3100, to prevent response to
SDF-1α. The blocking agents did not affect NPC viability as
examined with a TUNEL assay (Supplementary data 1). A third
group of NPC spheres was grown from E13 fetal brains of CCR2Figure 2 Neural precursor cells express several chemokine rece
receptor), c-Met (HGF receptor) and CCR2 (MCP-1 receptor), as show
was also detected by immunofluorescence staining (B–D), Scale barknock-out mice and labeled with BrdU. In addition, a fourth
group of NPC spheres from CCR2 knock-out fetal brains was
incubated with both anti-c-Met antibody and AMD3100 to
inhibit response to all three chemokines. Given the time-
limited effect of blocking agents on the receptors (Hatse et al.,
2002), we performed a short term experiment and evaluated
the extent of migration at 72 h post-transplantation. It shouldptors. Neurosphere cells express the receptors CXCR4 (SDF-1α
n by PCR (A). Strong expression of chemokine receptors in NPCs
: 0.1 mm.
Figure 3 Blocking of CXCR4, CCR2 and c-Met on NPCs inhibits their migration in the EAE brain. BrdU labeled NPCs from CCR2 ko
mice which were incubated prior to transplantation with the CXCR4 inhibitor AMD3100 and with an anti-c-Met blocking antibody were
co-transplanted with GFP+ NPCs (as controls) into the lateral ventricles of PLP-induced EAE SJL mice. While many GFP+ control cells
(green) exited the lateral ventricles and migrated extensively in the corpus callosum, the blocked BrdU+ cells (red) remained mostly
in the ventricle (A). Similarly, in MOG-induced EAE in C57Bl/6 mice, GFP+ control NPCs (green) exited the ventricle and migrated
extensively into the fimbria, whereas BrdU labeled NPCs (red) from CCR2 ko mice which were incubated with the AMD3100 and with
anti-c-Met antibody remained mostly in the ventricle (B). Scale bars: 0.25 mm.
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Figure 4 Quantification of the inhibition of NPC migration by
blocking chemokine receptors. The maximal distance of migration
in the corpus callosumwas compared in individual animals between
control GFP NPCs and BrdU-labeled NPCs, non-treated or in which
one or all three chemokine receptors were blocked. Blocking CCR2
or c-Met alone did not induce a significant effect on migration.
Blocking CXCR4 caused a mild inhibition of migration. Blocking all
three chemokine receptors induced a significant 31% inhibition of
NPC migration (A). The proportion of BrdU labeled cells as per
control GFP+ cells was assessed in the distal third segment of
migration. An equal number of BrdU+ and GFP+ cells will result in a
proportion of 1. Blocking each chemokine receptor alone caused
a 33–57% inhibition of NPC migration. When all three receptors
were blocked there was massive (81%) inhibition of NPC migration
(B). Number of animals per group: BrdU control: 2 mice, CXCR2: 5
mice, AMD3100: 4 mice, α-cMet: 4 mice and all chemokines: 7
mice.
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(72 h), the low immunogenicity of stem cells (Hori et al., 2003;
Mammolenti et al., 2004) and the universal nature of NPC
migration in response to neuroinflammation (Ben-Hur et al.,
2007), the allogeneic experimental design (transplantation of
C57Bl/6 derived NPCs into PLP-EAE SJL mice) did not pose any
issues of graft rejection. For each of these groups NPCmigration
was compared individually to co-transplanted control GFP+
NPCs. When all three blocking agents were used, profound
inhibition on NPC migration was observed (Fig. 3A). The extent
of migration was compared between treated and control NPCs
by two measures. First, the maximal distance of migration
represents the distance from the edge of the lateral ventricle
into which NPC spheres were transplanted to the most distant
migrating cell. The maximal distance of migration of CCR2 k-oNPCs that were also incubated with both AMD3100 and α-c-Met
antibody was significantly reduced by 31% (p b 0.001) in
comparison to control GFP cells (Fig. 4A). It was evident
that these measurements did not reflect the profound effect
that was observed microscopically, probably since some NPCs
evaded the effect of chemokine-receptor blockers. We there-
fore quantified also the number of migrating cells, and
specifically in the segment representing the last third of the
migration chain of control NPCs. When all three chemokine
receptors were blocked, the number of cells reaching the last
segment was reduced by 81% (p b 0.001) as compared to
control GFP+ NPCs (Fig. 4B). To examine the relative role of
each chemokine signaling system, we measured the migration
of NPCs inwhich only one chemokine receptor was blocked. The
maximal distance of migration of CCR2 k-o NPCs was not
significantly reduced as compared to that of control GFP+ cells.
Incubation of wild type NPCs with AMD3100 reduced the
maximal distance of migration by 12% (p = 0.02). Incubation
with anti-c-Met reduced NPC migration by 8% (not significant).
Blocking the effect of each chemokine resulted in partial
reduction in number of migrating cells. The proportion of CCR2
k-o NPCs was reduced by 40% (not significant), AMD3100-
treated NPCs by 57% (p = 0.002), and anti-c-Met-treated
NPCs by 33% (p = 0.087). In order to verify the consistency
of these results in another EAE model, we transplanted
CCR2 k-o BrdU-labeled NPCs incubated with AMD3100 and
α-c-Met together with GFP+ NPCs in 3 MOG-EAE C57Bl/6
mice at the peak of the disease (day 18). The mice were
euthanized after 72 h. Migration of the BrdU labeled NPCs
was massively inhibited compared to that of the control
GFP+ NPCs (Fig. 3B).Chemokine expression in the CNS during EAE
Our findings indicated a central role of CCR2, CXCR4 and
c-Met in mediating NPC migration in EAE. We therefore
examined the expression of their main related chemokines.
Stromal cell derived factor 1α (SDF-1α) and hepatocyte
growth factor (HGF) are the only known ligand of CXCR4 and
c-MET, respectively (Birchmeier et al., 2003). Monocyte
chemo-attractant protein 1 (MCP-1) is the major CCR2 ligand
in EAE mice (Huang et al., 2001). Immunofluorescent staining
was performed on brain slices to compare the actual presence
of these chemokines in naïve versus PLP-EAE conditions. Very
low levels of SDF-1α, MCP-1 and HGF were detected in naïve
brains. At the peak of EAE an increase in tissue staining of these
chemokines was observed, and mainly in white matter tracts,
such as the corpus callosum and fimbria (Figs. 5A–B). We
quantified also the chemokines by western blot analysis
(Fig. 5C). MCP-1 expression was significantly increased in EAE
brain tissue. SDF-1α was undetectable in naïve tissues and
barely detectable in the EAE corpus callosum and spinal cord
tissues, indicating a slight increase. Western blot analysis did
not show clear differences in HGF quantity between naïve and
EAE brains (Fig. 5C). Chemokine staining was not limited to
foci of perivascular inflammation but was induced in resident
glial cells throughout the white matter tracts (Figs. 5A–B).
Specifically, double immunofluorescent staining showed that
the expression of all three chemokines was induced in tissue
Iba-1+ and Mac-3+ macrophages/microglia (Fig. 6A) and in
GFAP+ astrocytes (Fig. 6B).
Figure 5 Immunofluorescent staining of SDF-1α, MCP-1, and HGF in naïve and EAE brains. There was negligible staining of the three
cytokines in naïve brains (A). There was diffuse tissue expression in the corpus callosum and fimbria of EAE mice (B). Western blot
analysis showed an increase in MCP-1 and SDF-1α protein levels in the spinal cord and corpus callosum of EAE mice (C). Prion protein
content was analyzed as a housekeeping protein. V = ventricle, CC = corpus callosum, fim = fimbria, SC = spinal cord. Scale bars:
0.1 mm.
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phenotype, induced by EGF
After establishing the role of tissue factors that trigger NPC
migration we examined whether intrinsic characteristics of
the NPCs affect their ability to respond to such environmen-
tal cues. Specifically, we examined whether NPC migratory
response depends on a motile phenotype which is acquired
by EGF supplementation.
Real time PCR was performed to examine the effect of EGF
deprivation on the expression of these receptors. There was a
non-significant change in the expression of CCR2 and c-Met.
In spheres grown only in FGF2 there was a 4-fold increase
in CXCR4 expression (Fig. 7A). However, immunofluorescent
staining showed a similar expression of these receptors on
NPCs grown only in FGF2 (Supplementary data 2).
In order to characterize the effect of EGF deprivation
on NPC motility they were plated on a poly-D-lysine andfibronectin coated substrate in vitro. Within 1 h after plating
there was strong outward migration of cells from spheres
that had been grown in EGF and FGF2 supplemented media,
but only negligible cell migration from spheres that had been
grown in FGF2 alone (Fig. 7B, chi square = 45.2, df = 2,
p b 0.001). This indicates that EGF improves motility of NPCs
regardless of any external cue. After an additional 4 days of
culture without growth factor supplementation, outward-
migrating NPC sphere cells that were previously grown with
FGF2 alone differentiated into neurons (38% ± 21%), astro-
cytes (28% ± 5%) and oligodendrocytes (34% ± 8%), whereas
outward-migrating cells from NPC spheres that had been
grown with FGF2 and EGF generated only astrocytes (32% ±
3%) and oligodendrocytes (58% ± 13%), and did not give rise
to neurons (less than 1%) (Figs. 7C–H). Therefore, EGF also
directs fetal NPC fate into glial lineages.
In view of EGF effect on NPC motility in-vitro, we
examined whether EGF deprivation affects NPC migratory
235Signaling through three chemokine receptors triggers migration of NPCs in a model of MSresponse to neuroinflammation. GFP+ NPC spheres that
were grown in FGF2 + EGF or FGF2 alone were ICV
transplanted at the peak of the disease (days 13–15 post
immunization in SJL EAE mice). The mice were euthanized
at 3 days post-transplantation and their brains processed
for histopathology. Brain sections were examined for cell
migration in the corpus callosum and other white matter
tract regions. NPCs grown in the presence of EGF and
FGF2 migrated extensively in white matter tracts (corpusFigure 6 Expression of chemokines by tissue glial cells. Confocal
expression of SDF-1α, MCP-1 and HGF in tissue Iba-1+/Mac-3+ microgcallosum and fimbria) of 47.5% of the brains (19 of 40 mice),
whereas migration of NPCs grown in the presence of
FGF2 alone was detected in only 12.5% of the brains (5 of
40 mice, Fig. 7I and J, chi square = 25.13, df = 1, p b 0.001).
In brains where NPC migration took place, the average
maximal distance reached by the cells was not significantly
different between the two groups (882 ± 484 μm for the FGF2
group and 955 ± 421 μm for the NPCs grown in EGF and FGF2,
p N 0.1).microscopy of double immunofluorescent staining showed the
lia (A) and in GFAP+ astrocytes (B). Scale bars: 25 μm.
Figure 7 EGF confers a motile and glial-only phenotype to NPCs, associated with improved therapeutic properties. There was no
significant change in the mRNA level of CCR2 and c-Met expression in neurospheres deprived of EGF, while expression of CXCR4 was
mildly increased (A). An in vitro motility assay was used to examine the effect of EGF by measurement of outward NPC migration from
the neurosphere after 1 h of adherence to coated plates. NPCs grown in FGF2 supplemented medium alone did not exhibit any
migration whereas in most of the NPC spheres grown in FGF2 and EGF supplemented medium there was an extensive outward
migration of more than two cell diameters (B). Neurosphere cells cultured with FGF2 alone express the neuronal marker βIII-tubulin
(C) whereas neurospheres cultured with FGF2 and EGF do not (D). Neurospheres grown with FGF2 and neurospheres grown with FGF2
and EGF express the oligodendrocyte progenitor marker PDGFR-α (respectively E and F) and the astrocyte marker GFAP (respectively
G and H). Scale bar: 0.1 mm. The migration of intracerebroventricular-transplanted GFP+ NPC spheres into white matter tracts in EAE
mice was examined by fluorescence microscopy. In the vast majority of EAE mice transplanted with NPC spheres grown in FGF2 only,
GFP+ cells remained in the ventricular space and did not migrate into the parenchyma (I). When NPC spheres were grown in FGF2 and
EGF there was an extensive migration into the white matter (J). V = ventricle, CC = corpus callosum, Scale bars: 0.1 mm.
Transplanted NPCs grown in FGF2 and EGF are superior to NPCs grown in FGF2 alone in ameliorating EAE clinical score. Mice were
transplanted with neurospheres cultured either with FGF2 or with FGF2 and EGF, 8 days after EAE induction. Neurospheres cultured
with FGF2 and EGF attenuated the severity of EAE, while neurospheres that were cultured in FGF2 alone exhibited a non-significant
effect. This was observed both in SJL mice PLP-EAE model (K) and in C57Bl/6 mice MOG-EAE model (L).
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237Signaling through three chemokine receptors triggers migration of NPCs in a model of MSIn order to examine whether induction of motility and
glial lineage preference was associated with a functional
phenotype, we examined the ability of NPCs grown in FGF2
alone or in FGF2 and EGF to attenuate PLP-EAE following ICV
transplantation in comparison to sham operated EAE SJL
mice. NPC spheres were transplanted (5000 spheres per
mouse, 7 SJL mice per experimental group) at day 8 post EAE
induction and animals were followed for 21 days. Disease
severity was compared between experimental groups (Fig. 7K).
In mice transplanted with NPCs grown in FGF2 alone there
was a mild, non-significant attenuation of disease severity as
compared to sham-operated EAE mice. In mice that were
transplanted with NPCs grown in FGF2 and EGF there was a
significant amelioration of disease severity, as indicated by
cumulative disease scores: 28.46 ± 16.07 for the control EAE,
21.4 ± 10.94 for the FGF2 alone group (p = 0.18) and 16.1 ±
9.85 for the FGF2 + EGF group (p = 0.05). A similar trend was
observed when NPC spheres were ICV transplanted into EAE
C57BL/6 mice induced by MOG33–55 peptide. Cumulative
disease score was 24.5 ± 14.2 for the EAE control group,
24.5 ± 7.8 for EAE mice transplanted with FGF2-spheres, and
15.0 ± 12.7 for EAE mice transplanted with FGF2 + EGF-
spheres (p = 0.09, Fig. 7L).Discussion and conclusion
In this report we show for the first time an additive role of
three chemokine receptor signaling systems, accounting for
most of the robust migratory response of neural precursor
cells to brain inflammation in the EAE model.
In vivo cell migration depends on three factors: cell
motility, environmental signals and the ability of the cell to
respond to these signals. In this study we examined the cell-
and tissue-derived factors that affect NPC migration in
response to brain inflammation in an experimental model of
MS.
First, cytokines and chemokines are mediators of inflam-
mation and strong chemo-attractant proteins. Specifically,
SDF-1α, MCP-1 and HGF play important roles in the
pathogenesis of EAE. MCP-1 is involved in mediating the
infiltration of macrophages and T-cells into the CNS during
EAE. MCP-1 deficient mice are resistant to EAE induction
(Huang et al., 2001) and the MCP-1/CCR2 signaling pathway
has become a potential target for MS therapy (Giraud et al.,
2010; Karpus et al., 2008). SDF-1α regulates the severity of
EAE (Meiron et al., 2008). It is thought to maintain the
integrity of the blood–brain barrier in normal condition and
its effect is disrupted in EAE (McCandless et al., 2006).
Furthermore, a recent study suggested that SDF-1α is
involved in the migration of oligodendrocyte progenitors
during EAE (Banisadr et al., 2011). The role of HGF in EAE is
controversial with reports on the promotion of macrophage
proliferation and a pro-inflammatory role (Moransard et al.,
2010) versus an immunomodulatory and neuroprotective
effect (Benkhoucha et al., 2010).
We observed that NPCs express the cognate receptors to
these chemokines. The absence of MCP-1 receptor CCR2
on NPCs, or blockage of HGF receptor c-Met or of SDF-1α
receptor CXCR4 resulted in the partial inhibition of NPC
migration. Only the blockage of all three receptors resulted
in a dramatic inhibition of NPC migration, indicating anadditive effect of the three chemokine receptor signaling.
Thus, CXCR4, CCR2 and c-MET signaling accounts for most of
the NPC migratory performance in the EAE mouse brain. It is
technically difficult to achieve total inhibition since the
blocking antibodies and specific receptor inhibitors are
limited in the length of action in time and some cells at
the core of the neurospheres can evade exposure to the
agents. However we do not exclude that additional inflam-
matory mediators may be involved in the induction of NPC
migration.
The blockage of the three chemokine receptors resulted
in the inhibition of migration in two different mouse strains,
SJL and C57Bl/6 with two different EAE models induced by
the proteins PLP and MOG respectively. This suggests that
the role of these chemokine systems may be universal in the
EAE model.
Since inflammation-induced NPC migration was depen-
dent on the three chemokine receptors' signaling, we
examined the expression of their major ligands. There was
an increase in tissue immuno-reactivity of SDF-1α, MCP-1
and HGF in the corpus callosum during EAE. Specifically,
induction of EAE was associated with chemokine staining
in activated tissue microglia and astrocytes. Our findings are
in agreement with previous reports on increased tissue
immuno-reactivity of SDF-1α in EAE and MS brain tissue
derived astrocytes and microglia (Banisadr et al., 2011; Moll
et al., 2009), and with the correlation between the Iba-1+
microglia density and NPC migration in EAE brain (Ben-Hur et
al., 2007).
A motile phenotype is required for enabling cellular
migratory response to these chemokine signaling. Epidermal
growth factor (EGF) is a powerful mitogen for NPCs and was
shown to increase motility of several cell populations
(Ayuso-Sacido et al., 2010; Boockvar et al., 2003; Fricker-
Gates et al., 2000). We show here that without EGF
supplementation, transplanted NPCs fail to respond to
inflammatory cues in almost 90% of EAE mice. The motile
phenotype induced by EGF was not due to the induction of
chemokine receptors (Fig. 7A and Supplementary Fig. 2) and
not dependent on any additional external signal as observed
in vitro (Fig. 7B). However, a motile phenotype is essential
for cell migration in response to inflammatory cues. In
addition, EGF supplementation influences NPC fate commit-
ment towards glial differentiation (Gonzalez-Perez et al.,
2009; Sanalkumar et al., 2010). Thus, glial committed NPCs
acquire superior migratory properties over multi-potential
NPCs in response to inflammation. This may be an important
property since regenerative therapy in MS is mostly aimed at
promoting remyelination. Therefore the final differentiation
of NPCs into mature myelinating oligodendrocytes is highly
sought (Ben-Hur, 2011; Gonzalez-Perez and Alvarez-Buylla,
2011). Indeed, NPCs grown in the presence of EGF and FGF2
achieved a stronger clinical effect when transplanted to EAE
mice than NPCs grown with FGF2 alone. Multiple studies
have shown that the main therapeutic effect of transplanted
NPCs in EAE is via their immunomodulatory and neurotrophic
properties, rather than participating directly in regenera-
tion (Ben-Hur et al., 2007; Einstein et al., 2006; Pluchino et
al., 2005). The improved therapeutic properties of FGF2-EGF
NPCs may be partly related to their increased motility and
glial preference, bringing them in close proximity to the site
of inflammation and injury.
238 M.E. Cohen et al.In MS, tissue injury is mediated by the inflammatory
process. CNS invasion by T cells and macrophages leads to
myelin sheaths' damage and loss of neural function. However,
inflammatory mediators may have a dual role, in which the
acute detrimental effects are followed by the initiation of
processes of repair (Lucas et al., 2006). If SDF-1α and HGF
indeed regulate EAE severity (Benkhoucha et al., 2010) as well
as mobilize tissue precursors, they may be considered as
therapeutic targets for regenerative therapy in MS. For MCP-1,
which seems to play a central role both in trafficking of
detrimental immune cells into the CNS and in inducing NPC
migration, then this apparent contradiction may be solved by
proper timing of its inhibition or induction. A better under-
standing of such dual functions of inflammatorymediators could
lead to the development of more effective therapies in MS.
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